294 related articles for article (PubMed ID: 11495391)
1. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
[TBL] [Abstract][Full Text] [Related]
2. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
[TBL] [Abstract][Full Text] [Related]
3. Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET.
Callen DJ; Black SE; Caldwell CB
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):899-906. PubMed ID: 12111130
[TBL] [Abstract][Full Text] [Related]
4. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
5. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of cerebral blood flow in frontotemporal lobar degeneration and Alzheimer's disease.
Nagao M; Sugawara Y; Ikeda M; Fukuhara R; Hokoishi K; Murase K; Mochizuki T; Miki H; Kikuchi T
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):162-8. PubMed ID: 15129697
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission computed tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population.
Scheltens P; Launer LJ; Barkhof F; Weinstein HC; Jonker C
Alzheimer Dis Assoc Disord; 1997 Jun; 11(2):63-70. PubMed ID: 9194952
[TBL] [Abstract][Full Text] [Related]
8. A new approach for improving diagnostic accuracy in Alzheimer's disease and frontal lobe dementia utilising the intrinsic properties of the SPET dataset.
Pagani M; Kovalev VA; Lundqvist R; Jacobsson H; Larsson SA; Thurfjell L
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1481-8. PubMed ID: 14579087
[TBL] [Abstract][Full Text] [Related]
9. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
[TBL] [Abstract][Full Text] [Related]
10. Memory functions and rCBF (99m)Tc-HMPAO SPET: developing diagnostics in Alzheimer's disease.
Elgh E; Sundström T; Näsman B; Ahlström R; Nyberg L
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1140-8. PubMed ID: 12192558
[TBL] [Abstract][Full Text] [Related]
11. Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease.
Bradley KM; O'Sullivan VT; Soper ND; Nagy Z; King EM; Smith AD; Shepstone BJ
Brain; 2002 Aug; 125(Pt 8):1772-81. PubMed ID: 12135968
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.
Koulibaly PM; Nobili F; Migneco O; Vitali P; Robert PH; Girtler N; Darcourt J; Rodriguez G
Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851
[TBL] [Abstract][Full Text] [Related]
13. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.
Sjögren M; Gustafson L; Wikkelsö C; Wallin A
Dement Geriatr Cogn Disord; 2000; 11(5):275-85. PubMed ID: 10940679
[TBL] [Abstract][Full Text] [Related]
15. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies.
Pasquier J; Michel BF; Brenot-Rossi I; Hassan-Sebbag N; Sauvan R; Gastaut JL
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1342-8. PubMed ID: 12271417
[TBL] [Abstract][Full Text] [Related]
16. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.
Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A
Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral blood flow assessed with 99mTc-ECD SPET as a marker of progression of mild cognitive impairment to Alzheimer's disease.
Encinas M; De Juan R; Marcos A; Gil P; Barabash A; Fernández C; De Ugarte C; Cabranes JA
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1473-80. PubMed ID: 14579086
[TBL] [Abstract][Full Text] [Related]
18. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
[TBL] [Abstract][Full Text] [Related]
19. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
20. Selecting the most relevant brain regions to discriminate Alzheimer's disease patients from healthy controls using multiple kernel learning: A comparison across functional and structural imaging modalities and atlases.
Rondina JM; Ferreira LK; de Souza Duran FL; Kubo R; Ono CR; Leite CC; Smid J; Nitrini R; Buchpiguel CA; Busatto GF
Neuroimage Clin; 2018; 17():628-641. PubMed ID: 29234599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
